TORONTO, Jan. 7, 2014 /CNW/ - China Health Labs & Diagnostics Ltd. ("China Health" or the "Company") (TSXV:CHO) announced that its going private transaction by way of share consolidation and compulsory redemption was completed on December 30, 2013 and the cash consideration of CAN$0.62 per share (pre-consolidated basis) was paid to registered shareholders on January 6, 2014. Beneficial shareholders (i.e., shareholders holding through brokers, investment dealers, banks, trust companies or other nominees) who held shares should contact their broker, or such other intermediary who held shares on their behalf, to confirm or arrange for the delivery of the consideration to which they are entitled. The common shares of the Company will be delisted from the TSX Venture Exchange and the Company will be notifying or applying to the applicable Canadian securities regulatory authorities to cease to be a reporting issuer in each province in which it is a reporting issuer.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: CHINA HEALTH LABS & DIAGNOSTICS
For further information: Chao Zhang, Chief Financial Officer, China Health Labs & Diagnostics Ltd., T: 1-416-865-3351, Email: email@example.com